ACXP Acurx Pharmaceuticals, Inc.

NASDAQ
$0.94

Acurx Pharmaceuticals, Inc. (ACXP) Earnings News

Earnings press releases, previews and reviews for Acurx Pharmaceuticals, Inc. (ACXP), newest first. Our most recent is review: Acurx Misses Q3 Loss Estimate as Dilution Drives the Per-Share 'Improvement'; PATHFINDER Starts Early but Funding Pressure Grows.